Exodus Point Capital Management, LP Athenex, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.79 - $1.59 $54,517 - $109,724	-69,009 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$1.36 - $2.94 $115,288 - $249,226	-84,771 Reduced 55.12%	69,009 $94,000
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $456,726 - $744,295	153,780 New	153,780 $463,000
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $60,873 - $84,173	-16,408 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $66,944 - $242,018	16,408 New	16,408 $71,000

Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $1.03 Million - $1.31 Million	-93,493 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $959,238 - $1.36 Million	93,493 New	93,493 $1.13 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.